*Other Operating Data Consensus Source: Bloomberg
More on Johnson & Johnson
- Is Johnson & Johnson A Dividend Stock, Or Something Else?
- Johnson & Johnson: Tempering Expectations After A Massive 2025 (Downgrade)
- Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Johnson & Johnson Non-GAAP EPS of $2.46 in-line, revenue of $24.6B beats by $440M
- Johnson & Johnson Q4 Preview: Strength in core portfolio keeps analysts bullish